ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ENVB Enveric Biosciences Inc

0.938
0.056 (6.35%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Enveric Biosciences Inc ENVB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.056 6.35% 0.938 09:30:50
Open Price Low Price High Price Close Price Previous Close
0.94 0.898 0.9594 0.938 0.882
more quote information »

Recent News

Date Time Source Heading
26/3/202422:00BWEnveric Biosciences Reports Financial Results and Provides..
19/3/202422:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
12/3/202422:00BWEnveric Biosciences Announces New Patent Issuances..
12/3/202403:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/3/202423:00EDGAR2Form 8-K - Current report
29/2/202423:00EDGAR2Form 8-K - Current report
29/2/202423:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
27/2/202408:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202408:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202400:00BWEnveric Biosciences Agrees to Sell Cancer-Targeting..
22/2/202400:05EDGAR2Form 8-K - Current report
22/2/202400:00BWEnveric Biosciences Unveils Library of Preclinical Compounds..
15/2/202407:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/2/202400:05EDGAR2Form 8-K - Current report
07/2/202402:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202409:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202400:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
12/1/202408:43EDGAR2Form S-3 - Registration statement under Securities Act of..
09/1/202408:42EDGAR2Form 8-K - Current report
04/1/202400:05EDGAR2Form 8-K - Current report
30/12/202308:43EDGAR2Form 8-K - Current report
30/12/202300:52BWEnveric Biosciences Announces Exercise of Warrants and..
29/12/202300:05EDGAR2Form 8-K - Current report
29/12/202300:00BWEnveric Biosciences Selects EB-003 as Lead Drug Candidate..
28/12/202300:05EDGAR2Form 8-K - Current report
28/12/202300:00BWEnveric Biosciences Reports Year End Progress for..
21/12/202300:00BWEnveric Biosciences to Participate in Biotech Showcase 2024..
07/12/202308:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
06/12/202300:05EDGAR2Form 8-K - Current report
06/12/202300:00BWEnveric Biosciences Selects Development Candidates from..
02/12/202308:31EDGAR2Form S-1/A - General form for registration of securities..
30/11/202300:18EDGAR2Form 8-K - Current report
30/11/202300:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
28/11/202300:00BWEnveric Biosciences Announces Manuscript Describing the..
25/11/202300:00BWEnveric Biosciences Announces Presentation of Two Posters at..
23/11/202308:30EDGAR2Form 8-K - Current report
14/11/202308:10EDGAR2Form 8-K - Current report
14/11/202308:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:01BWEnveric Biosciences Reports Third Quarter 2023 Corporate and..
07/11/202300:05EDGAR2Form 8-K - Current report
03/11/202308:29EDGAR2Form 8-K - Current report
31/10/202323:05EDGAR2Form 8-K - Current report
31/10/202323:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
20/10/202323:05EDGAR2Form 8-K - Current report
20/10/202323:00BWEnveric Biosciences to Present at the Centurion One 5th..
18/10/202323:05EDGAR2Form 8-K - Current report
18/10/202323:00BWEnveric Biosciences Initiates GLP Toxicology & Safety..
11/10/202323:05EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock